An observational study in Infant and Newborn, sponsored by University of Oxford. Recruiting at 1 site in United Kingdom. Open to participants aged Up to 42 Weeks. Per ClinicalTrials.gov, last updated 2023-12-21.
Sponsored by University of Oxford · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Premature Birth by University of Oxford — 3 open to participants now, 4 under way, none of them phase 3. Premature Birth · University of Oxford.
Among the 11 studies in Premature Birth by University of Oxford, this one is one of 2 that started in 2023, is one of 9 observational ones, and was the 9th registered.
2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.
Browse Premature Birth studies →3 of the 11 studies in Premature Birth by University of Oxford are open now, in 1 country. Recruiting first, the newest first:
University of Oxford · Sites in United Kingdom
Ages up to 37 wk
University of Oxford · Sites in United Kingdom
Ages 3–9
By country, each count listing its studies:
Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.
This study: Up to 42 Weeks · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 2 started in 2023.
This study's planned enrollment of 200 is above the median of 120 across 809 observational studies indexed under Premature Birth.
Median enrollment 1,504 across the 2 interventional studies, 200 across the 9 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Oxford is the lead sponsor of 813 studies on the registry; 119 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 11 studies in Premature Birth by University of Oxford, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
1 in 7 babies require neonatal care. During their time in hospital their vital signs (such as heart rate, breathing rate and oxygen saturation) are continuously monitored as part of standard care. Many factors lead to changes in vital signs, for example, medical procedures such as blood tests can result in brief increases in heart rate. Medication can also alter vital signs, either as an intended effect or as a side effect. However, different infants will respond in different ways to both procedures and medication. Predicting how an individual infant may respond could lead to better individualised care for infants. For example, using an infant's baseline vital signs to predict whether they will experience cardiorespiratory side effects from a particular drug could mean that doctors could choose an alternative safer treatment plan. To develop these predictive models, it is essential to first better understand how infants' vital signs are affected by different procedures and drugs, and how these effects are impacted by other factors such as infection, other pathologies, interaction between drugs and age.
Despite their routine use in hospital neonatal units, detailed electronic records of vital signs are often not recorded. Often, only major events or average values are stated on clinical records. Subtle changes in vital signs are therefore missed, and more complex analysis that may reveal important predictive features within the data is not possible. In this study the investigators will electronically record infant vital signs across longer time periods and during a variety of clinically-necessary procedures and administration of drugs, to explore how these impact vital signs and are altered by factors such as age and pathology. These will be compared with control procedures, such as a nappy change, or when the infant is resting in their cot or receiving skin-to-skin care.
This single-centre prospective observational exploratory study will take place at the John Radcliffe Hospital, Oxford. Participants will be infants receiving inpatient care on the Newborn Care Unit.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Infants will be eligible to be included in the study if they are:
Exclusion Criteria:
Infants will be ineligible if the following exclusion criteria applies:
Change in heart rate following drug administration
To characterise the change in heart rate in infants following drug administration in a wide range of commonly used drugs in neonatal care. Drugs will only be administered as part of clinical care, no drugs are administered for research purposes
Time frame: 1 day after drug administration, compared with baseline of 1 day before drug administration.
Change in oxygen saturation following drug administration
To characterise the change in oxygen saturation in infants following drug administration in a wide range of commonly used drugs in neonatal care. Drugs will only be administered as part of clinical care, no drugs are administered for research purposes
Time frame: 1 day after drug administration, compared with baseline of 1 day before drug administration.
Change in respiratory rate following drug administration
To characterise the change in heart rate in infants following drug administration in a wide range of commonly used drugs in neonatal care. Drugs will only be administered as part of clinical care, no drugs are administered for research purposes
Time frame: 1 day after drug administration, compared with baseline of 1 day before drug administration.
Change in heart rate following procedures
To characterise the change in heart rate in infants in relation to procedures, including (but not limited to) intubation and extubation, LISA (less invasive surfactant administration), blood transfusion and acute medically-required painful procedures.
Time frame: 1 day after procedure, compared with baseline of 1 day before procedure.
Change in oxygen saturation following procedures
To characterise the change in oxygen saturation in infants in relation to procedures, including (but not limited to) intubation and extubation, LISA (less invasive surfactant administration), blood transfusion and acute medically-required painful procedures.
Time frame: 1 day after procedure, compared with baseline of 1 day before procedure.
Change in respiratory rate following procedures
To characterise the change in respiratory rate in infants in relation to procedures, including (but not limited to) intubation and extubation, LISA (less invasive surfactant administration), blood transfusion and acute medically-required painful procedures.
Time frame: 1 day after procedure, compared with baseline of 1 day before procedure.
Models of drug response
Prediction of drug regimen requirements in individual infants from respiratory rate.
Time frame: 1 day after drug administration, compared with baseline of 1 day before drug administration.
Models of procedure response
Prediction of procedure outcome in individual infants (e.g. extubation success) from respiratory rate
Time frame: 1 day after procedure, compared with baseline of 1 day before procedure.
Started Sep 2023 (actual). Primary completion is estimated for Sep 2024, 11 months after the start.
Of 373 non-industry observational studies under Premature Birth, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 63. This study's planned 11 months is below that.
Counting every sponsor, half of 388 studies reached it within 35 months; a quarter within 19 and three quarters within 61.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.